TMCnet News

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Envision Healthcare Corporation Investors
[July 25, 2017]

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Envision Healthcare Corporation Investors


Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Envision Healthcare Corporation ("Envision" or the "Company") (NYSE: EVHC) for allegedly issuing false and/or misleading information to Envision investors. To obtain information or aid in the investigation, please visit the Envision investigation page on our website at www.glancylaw.com.

On July 24, 2017, The New York Times reported that physicians associatd with Envision's subsidiary EmCare Holdings Inc. were disproportionately likely to engage in practices referred to as "surprise billing" in which patients who go to in-network hospitals are treated by out-of-network doctors and subsequently billed at higher rates.



On this news, shares of Envision fell $2.33 per share or over 3% on July 24, 2017, thereby damaging investors.

Follow us for updates on Twitter (News - Alert): twitter.com/GPM_LLP.


If you purchased Envision securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


[ Back To TMCnet.com's Homepage ]